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Amyloid oligomers are considered to play causal roles in the pathogenesis of amyloid-related degenerative
diseases including Alzheimer’s disease. Using MD simulation techniques, we explored the contributions of
the different structural elements of trimeric and pentameric full-length A1-42 aggregates in solution to their
stability and conformational dynamics. We found that our models are stable at a temperature of 310 K, and
converge toward an interdigitated side-chain packing for intermolecular contacts within the two -sheet regions
of the aggregates: 1 (residues 18-26) and 2 (residues 31-42). MD simulations reveal that the -strand
twist is a characteristic element of A-aggregates, permitting a compact, interdigitated packing of side chains
from neighboring -sheets. The 2 portion formed a tightly organized -helix, whereas the 1 portion did not
show such a firm structural organization, although it maintained its -sheet conformation. Our simulations
indicate that the hydrophobic core comprising the 2 portion of the aggregate is a crucial stabilizing element
in the A aggregation process. On the basis of these structure-stability findings, the 2 portion emerges as
an optimal target for further antiamyloid drug design.
Introduction
Proteins can adopt an amazing array of sequence-dependent
structures that enable them to perform the myriad of chemical
functions critical to life. However, over the past decade, it has
become clear that many different proteins can also form
misfolded structures leading to insoluble aggregates. With
respect to human brain functioning, protein misfolding can have
dramatic consequences and can result in devastating diseases
of the brain. There are several known degenerative diseases
whose pathogenic mechanism is based on the pathological
aggregation of polypeptides. These types of neurodegenerative
diseases include Alzheimer’s disease (AD), Parkinson’s disease,
Huntington’s disease, prion diseases like Creutzfeldt-Jacob
disease, and type II diabetes.1-3 It is a common feature to all of
the above-mentioned diseases that the native structure of the
specific peptides has been changed and that, during a fast
aggregation process, they provide fibrillary products which are
toxic to nerve cells or nervous tissue and resistant against
enzymatic breakdown. The most extensively studied amyloid-
associated disease is AD, which is characterized pathologically
by abnormally high numbers of amyloid or senile plaques in
the cerebral cortex and amyloid deposits in the walls of cerebral
blood vessels, and by neurofibrillary tangles in dead and dying
neurons.4 Amyloid plaques are brain lesions that are composed
of amyloid polymers and degenerating neurites accompanied
by activated microglia, the inflammatory cells of the brain. The
major component of amyloid plaques is a small peptide of
39-43 amino acids in length called -amyloid (A), which is
a proteolytic splicing product of the large amyloid precursor
protein (APP). Compelling evidence now indicates that factors
which increase the production of amyloidogenic variants of A,
or which facilitate deposition or inhibit elimination of amyloid
deposits, are major risk factors for AD.5
Currently, more than 20 different forms of A are known,6
some of which are rare and some of which play central roles in
the pathogenesis of diseases affecting millions of patients
worldwide. The investigation of amyloid, as a major example
of pathology due to protein misfolding, has become a widely
studied enterprise.7-13 Consequently, the 3D structure of the
amyloid polymers and fibrils is a focus of interest both for a
molecular understanding of amyloidogenesis and for the de-
velopment of innovative therapeutic and diagnostic approaches.
Solid-state NMR studies have contributed substantially to the
understanding of amyloid fibrils.14,15 However, only a few 3D
structures of amyloid fibrils have yet been determined,16,17 owing
in part to the fibrils’ noncrystalline, insoluble, and mesoscopi-
cally heterogeneous nature. This makes these structures difficult
to access by established structural techniques such as X-ray
crystallography or solution-state NMR.18 Since the 1970s,
amyloid has been defined by its main -sheet fibrillary
structure,19-21 and by properties associated with this. The
unifying structure is an assembled protein fibril in which the
sheets are parallel to the fibril direction and where the strands
run perpendicular to the fibril. This principal organization is
believed to be common to all amyloid fibrils, irrespective of
the biochemical nature.13
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The amyloid beta 1-42 peptide (A1-42) fragment is the
dominant A-species in the amyloid plaques of AD patients,
and compared with the amyloid beta 1-40 peptide (A1-40), it
displays a dramatically increased propensity to form amyloid
fibrils in Vitro.22-25 Furthermore, a comparison of the kinetic
data of A1-40 and A1-42 shows that A1-40 adopts more varied
conformational structures compared to A1-42, as seen by the
fluctuations of the Tyr signal displayed by A1-40.26 A compara-
tive experimental-theoretical conformational study has been
carried out by Sgourakis et al.,27 which sheds light on the
differential conformational behavior of the monomers in aqueous
solution of A1-40 and A1-42. The presence of metal ions, in
particular copper, zinc, and iron, has been reported to enhance
A aggregation.28-30 Several important structural characteristics
of A1-42 fibrils have been determined,14-18 establishing that
A1-42 fibrils form a cross- structure31 that contains parallel,
in-register -sheets.32 Most recently, it was found that memory
deficits in middle-age transgenic AD model mice are caused
by the extracellular accumulation of a dodecameric A1-42
soluble assembly.12 While the major toxic species in AD are
probably A-oligomers, thus being a principal target of AD drug
development, it remains unclear why A-oligomers should be
neurotoxic. Plausible mechanisms of toxicity include links to
oxidative stress, metal binding, free radical formation,33 or ion
channel formation,34 and therefore, it may be possible to interact
with these processes by applying reducing agents, metal
chelators,35 or ion channel inhibitiors. In general terms, an ideal
approach would be to interfere with the early phases of
molecular pathways that lead to the disease. Consequently, one
attractive therapeutic strategy for the treatment of AD is to
inhibit A-peptide aggregation, since this appears to be one of
the first steps in the pathogenic process of amyloidosis that is
not associated with some natural biological function.36 Breaking
these amyloid aggregates down by nonpeptide or peptide
inhibitors seems to be a promising way to combat AD.37 To
that aim, it is crucial to understand the conformational and
dynamic behavior of the structure of the A1-42 aggregates in
order to rationally design a putative AD drug. Moreover, the
conformational analysis and the investigation of the structure
of A1-42 aggregates might lead to a more profound understand-
ing of the primary pathogenesis of AD and comprehension of
the development at the molecular level of this dramatic disease.
Most computational investigations of the structure and
dynamics of A-peptides have focused on monomers,11,27,38-47
dimers,48-50 and other low-order oligomers.8,51-56 The idea of
considering a full-length molecular model of the A-aggregates
is worthy of consideration, since the majority of the studies
mentioned above have employed models using a truncated-
sequence molecular model and/or insoluble fibril state. In our
present investigation, profiting from the structural information
available from recent solid-state nuclear magnetic resonance
(ssNMR) experiments16,32,39,41,57,58 on the parallel cross- struc-
ture of A-protofilaments, we perform all-atom/explicit solvent
simulations of amyloid aggregates containing three and five
peptide units. Every unit with “hairpin” shaped A1-42 peptides
was located in a plane roughly perpendicular to the fibril axis,
as it was observed by using ssNMR.16 Among the different
structural topologies possible depending on the experimental
growth conditions,39,41,58 we focus on A1-42 fibrils grown under
the conditions defined as in ref 16. The objectives of our study
are twofold: (1) to explore the contributions of the different
structural elements to the stability of full-length aggregated
A1-42 in solution and (2) to investigate the most promising,
potential structural target for further drug design based on the
structure-stability information of our model. Our reasonably
long-time simulations (100 ns) of both tri- and pentameric
aggregates at 310 K, in which fibrils are experimentally stable
(below ∼330 K), permit us to draw conclusions on structurally
relevant aggregate characteristics such as the secondary-to-
quaternary structural elements (e.g., -strands, intra- and
intermolecular contacts), internal salt-bridges, and interior
hydration. In the present study, we analyze the evolution of these
elements at 310 K, focusing in particular on the structure and
dynamics behavior in solution of the full-length A1-42 aggregates.
Methods
System Setup. The human amyloid beta 1-42 peptide
(A1-42) (Figure 1) was taken as a model system. The
calculations were carried out using the structure of the A1-42
fibrils (PDB entry 2BEG) determined by Lührs and co-workers16
that was downloaded from the Protein Data Bank.59 Due to the
fact that residues 1-17 are disordered and lacking a unique
and stable conformation, we only had experimental structural
information from residues 18-42.16 Therefore, in order to have
the completed molecule of A1-42, the sequence for the residues
1-17 was completed using an arbitrary totally extended
orientation (φ = 180° and ψ = 180°). Both trimeric and
pentameric aggregates were investigated. The trimeric system
was obtained by deletion of the edging chains of the experi-
mental structure determined by Lührs and co-workers,16 which
is a pentameric aggregate. Protons were added using the program
pdb2gmx, in the GROMACS suite of programs, for optimization
of the hydrogen bond network.
The peptide aggregates were embedded in a rectangular box
containing SPC waters,60 leaving at least 10 Å between the
solutes and the edge of the box. The total number of water
molecules varied between 15 630 and 25 919. Na+ ions were
added to the systems by replacing water molecules in random
positions, thus making the whole system neutral (Table 1). In
order to equilibrate our systems, we carried out an extensive
simulated annealing (SA) protocol with repeating heating/
Figure 1. Amino acid sequence of human amyloid beta 1-42 peptide (A1-42) and schematic representation of a molecule of A1-42 in a hairpin
shape. The residues 1-17 comprise the disordered region. The residues 18-42 comprise the -sheet region.






































































cooling cycles covering a broad temperature range (from 310
up to 500 K), in which fibrils are experimentally stable (below
∼330 K) or fully dissociated (above ∼373 K).61,62 During the
whole minimization position, restraint was applied for the alpha
carbons (CR) of residues 18-42. As a result of the SA runs,
the disordered region (DR) residues showed a large range of
conformational sampling. Multiple simulations were performed
for each system, starting from different initial random velocity
distributions, generating five independent strands of simulations
(labeled A-E, see Table 1). Details of the equilibration
procedure can be found in the Supporting Information. For each
strand between 20-100 ns, production runs were obtained and
analyzed. The coordinates were saved every 2 ps.
Simulation Parameters. All simulated annealing (SA)
simulations and molecular dynamics (MD) simulations were
performed using the GROMACS 3.3.2 package of programs,63
with the OPLS-AA force field.64 The simulations were run under
NPT conditions, using Berendsen’s coupling algorithm65 for
keeping the temperature and pressure constant (P ) 1 bar, τP
) 0.5 ps; T ) 310 or 500 K, τT ) 0.1 ps). The LINCS
algorithm66 was used to constrain the lengths of hydrogen
containing bonds; the waters were restrained using the SETTLE
algorithm.67 A force constant of 1000 kJ mol-1 nm-1 was used
for position restraints during the SA. For the subsequent
unrestrained MD simulations, the same parameters were used
as for the restrained MD, except that the temperature was
maintained at 310 K and no positional restraints were applied.
The time step for the simulations was 0.002 ps and the
compressibility 4.8 × 10-5 bar-1. van der Waals forces were
treated using a 1.2 nm cutoff. Long-range electrostatic forces
were treated using the particle mesh Ewald method (PME).68
Analysis. The analysis of the simulations was performed
using the analysis tools provided in the Gromacs package. The
root mean square deviation (rmsd) of backbone atoms and the
total and potential energies were calculated. The root mean
square fluctuation (rmsf) of the backbone atoms and the
hydrophilic, hydrophobic, and total solvent accessible surface
area (SASA) were also determined. The total number of
hydrogen bonds in the peptide group was quantified by counting
acceptor and donor atom pairs that are not further apart than
0.35 nm.69 Secondary structure analysis used DSSP.70 All
molecular graphical presentations were created by VMD71 and/
or UCSF Chimera72 packages. The standard deviation of every
given value is shown in parentheses.
Results and Discussion
To more clearly present the results obtained with our
simulations, we have divided our system into two regions. The
first region encompasses residues 1-17, which is very likely
to be a region with a large degree of flexibility. We will refer
to this region as the “disordered region” (DR). The second
region comprises residues 18-42, which is the -sheet region
(R). The R presents a -strand-turn--strand motif (hook-
like or hairpin shape) that contains two intermolecular, parallel,
in-register -sheets that are formed by residues 18-26 (1) and
31-42 (2) connected by a turn formed by residues 27-3016
(Figure 1). Figure 2 shows the superposition of five structures
collected every 2 ns of SA of the pentameric system, which
form the starting structures of the five independent simulations
performed (denoted strands A-E). In Figure 2, a high degree
of mobility of the DR is clearly visible. A similar result was
observed for the trimeric system. Using the final structures
obtained by the simulated annealing (SA) protocol as starting
structures for the MD simulations, we initially generated 20 ns
trajectories for each of the strands. Although the potential
energies of the systems quickly equilibrate over a period of 100
ps (see Figure S3, Supporting Information), it became clear that
20 ns is too short to reach equilibrium in the overall structural
properties of the aggregates, e.g., -helix formation. Therefore,
we extended two of the simulations, for both the trimeric and
pentameric systems, to 100 ns. The first 20 ns of these
simulations is considered equilibration time. The results de-
scribed and discussed in the remaining part of this paper are
mainly based on the extended simulations, corresponding to
string E; nevertheless, strings A-D have shown similar results.
Figure 3 shows snapshots of the trimeric and pentameric
aggregates at 0 and 100 ns of simulation. Top and lateral views
are shown. The average values of the properties (e.g., rmsd and
angles) are calculated only considering the last 80 ns of the
simulations. Figure 4 displays the evolution of rmsd’s and rmsf’s
for the E simulations. As a general feature, it can be observed
that the trimeric system compared to the pentameric form
displays a higher flexibility. Parts A and C of Figure 4 show
the evolution of the rmsd for the DR and the R (and its
subdivisions; 1, turn, and 2) for simulations E3 and E5. The
portions 1 and turn showed the higher fluctuations of rmsd.
This flexibility can also be appreciated in parts B and D of
Figure 4, which show the rmsf values per residue per chain. It
was observed in all simulations (strings A-E) and as a general
feature that the trimeric aggregate is structurally more flexible
than the pentamer. This fact may be attributed to the higher
degree of packing that a pentameric aggregate has in comparison
with the trimeric one. Especially in the case of the trimeric
aggregate, generally large fluctuations in rmsd occurred for the
1 and turn portions with an average value of 0.43 (0.06) and
0.44 nm (0.08), respectively. On the other hand, it is interesting
to note that the 2 portion reached an average rmsd value of
0.34 nm (0.02) after ∼12 ns of simulation (Figure 4A). This
can be correlated with the formation of a -helix structure in
this portion of the aggregate. Nevertheless, in the case of
pentameric aggregates, generally no large rmsd fluctuations were
observed. For pentamers, the largest rmsd value was observed
for the 1 portion with 0.41 nm (0.03), while the turn portion
revealed the smallest rmsd value of 0.24 nm (0.03). The 2
portion showed an average rmsd value of 0.30 nm (0.03) (Figure
4C) which was smoothly reached after 20 ns of simulation, and
which can be attributed to the formation of a -helix structure
in this portion of the aggregate. A good correlation with what
was observed for rmsd profiles can be appreciated in parts B
TABLE 1: Selected Parameters Used in Simulations A-E,
Including Molecular Dynamics (MD) Simulation Code,
Number of A1-42 Chains per System (# A), Number of
Na+ Ions Added for Neutrality (# Na+), Number of Water
Molecules per Simulation (# H2O), Total Number of
Atoms per System (#atoms), and Total Simulation Time
(time, in ns)
MD # A # Na+ # H2O # atoms time
A3 3 9 17 284 53 742 20
B3 3 9 17 284 53 742 20
C3 3 9 17 302 53 796 20
D3 3 9 15 630 48 780 20
E3 3 9 17 284 53 742 100
A5 5 15 25 919 80 907 20
B5 5 15 21 200 66 750 20
C5 5 15 20 832 65 646 20
D5 5 15 20 832 65 646 20
E5 5 15 20 009 63 177 100






































































and D of Figure 4, which show the rmsf values for each portion
of the trimeric and pentameric aggregate, respectively. The
highest rmsf values were observed for amino acid residues
located in the DR, 1, and turn portions for the trimeric
aggregate, while for the pentameric aggregate this was mainly
seen in DR and 1 portions (Figure 4B and D). Interestingly,
in the vicinity of each Gly residue (residues 9, 25, 29, 33, 37,
and 38), rmsf values increased due to the natural lack of side
chains of this amino acid residue. It is worth noting that the
lowest RMDF values, in all simulations for both trimeric and
pentameric aggregates, were observed for those amino acid
residues located in the 2 portion.
Figure 5A and B illustrates the temporal development of the
secondary structure content for the trimeric and pentameric
aggregates, along the 100 ns trajectory. In Table 2, the secondary
structure content for the DR and R is summarized. For all
simulations, both 1 and 2 portions are stable at room
temperature for the duration of the simulations. Even peptides
located at the ends of the aggregate present stable -strand
regions, with the occasional loss of -sheet content in the 1
portion. A small content of R-helix and 310-helix structures is
infrequently observed for the DR. These kinds of helices are
notably present with peptides at the edge of the aggregate. As
a general phenomenon, the loss of structure is more pronounced
in the trimeric aggregates, indicating that, at least at the finite
lengths studied here, they are more structurally flexible than
the pentamers. The loss of structure, especially of the -strand
motifs, of peptides from the aggregate ends seems to start at
the 1 and in the turn portions, while the core of the aggregate
comprised of the 2 portion remains largely intact. On the other
hand, transient helical conformations in the N-terminal residues
(Figure 5) were also reported in previous fibril formation
experiments and simulations.45,49,73,74 Figure 6 shows the average
interchain distances of the mass center of the CR’s at the various
regions of our systems. A large fluctuation can be appreciated
for the turn portion in simulation E3, which suggests a great
mobility in this portion of the aggregate. The DR showed an
average value of 0.77 nm (0.04), which is also slowly reached
(after ∼40 ns) by the 1 portion with an average of 0.72 nm
(0.09), indicating that these two parts of the molecule behave
similarly with respect to interchain mobility. It is interesting to
note the great influence that the DR has over the 1 portion.
The 2 portion showed the lowest fluctuation as compared to
the other portions, and also the lowest average value of 0.42
nm (0.03), suggesting a low interchain mobility and a great
Figure 2. Overlapped stereoviews of five configurations collected every 2 ns of simulation from the simulated annealing of the pentameric aggregate:
(A) top view indicating the CR position restraint zone; (B) lateral view.
Figure 3. Snapshots at 0 and 100 ns of simulation of the trimeric and
pentameric aggregates. Top and lateral views are shown.






































































compactness in this portion (Figure 6A). A very similar pattern
was observed for the pentameric aggregate of the 2 portion
with respect to mobility and compactness. In this case, an
average value of 0.45 nm (0.01) was rapidly and smoothly
reached (Figure 6B). On the other hand, the DR region showed
a general trend toward a larger interchain distance (1.21 nm
(0.02) for simulation E5), while the 1 portion did not follow
the same pattern as the DR which we found for the trimeric
aggregate. Therefore, the 1 portion in the pentameric config-
uration appears to be more compact (0.66 nm (0.04)) than the
1 portion of the trimeric aggregate. Interestingly, the turn
portion in the pentamers showed a smaller fluctuation than the
same portion in the trimers, suggesting that this as well as the
1 portion has a lower interchain mobility and a higher
compactness (0.53 nm (0.02)) in the pentameric aggregate. Very
similar interchain distances in the center of mass were seen for
the Ccarbonyl’s and C’s of each portion in our system (see Figure
S4, Supporting Information). These results, especially the
behavior of the 2 portion, are in good agreement with the
experimental findings of Balbach et al.32 for a parallel -sheet
organization, who reported the nearest-neighbor intermolecular
distances of 4.8 ( 0.5 Å for carbon sites. At this point, we
emphasize the high stability observed for the 2 portion, which
suggests a possible mechanism for fibril elongation, as was
previously reported.55 Hypothetically, in a first step, the initial
monomer addition at the end of a growing aggregate would be
driven by strong hydrophobic interactions stabilizing the 2
portion. In a second stage, the less stable 1 portion would form,
finally followed by the more flexible turn with its relatively
hydrophilic residues adopting the fibril conformation. On the
other hand, it was also observed for A1-42 monomers in
solution that the sequence I31IGLMVGGVVIA42 (namely, the
2 portion) may be responsible for the higher propensity of this
peptide to form amyloids.27
Consistent with ssNMR data on amyloid fibrils,39,41,57 all of
our starting fibril conformations have Asp23/Lys28 salt-bridge
contacts in the loop region. Other studies also showed that
charged residues are important for the dynamics of protein
aggregation and the stability of -sheet structures.54,73,75,76
Consistent with previous results,40,55 our trajectories of both
trimeric and pentameric aggregates reveal that the Asp23/Lys28
bridges are maintained at 310 K. Figure 7 shows the distance
between the center of mass of the carboxyl group of Asp23 and
the center of mass of the NH3+ group of Lys28, as well as a
simplified image of the starting configuration and the config-
uration after 100 ns of simulation for the pentameric case. It
can be appreciated that the positive and negative charges
alternate along the fibril axis as in a one-dimensional ionic
crystal. We observed that both trimeric and pentameric ag-
gregates form intrachain salt-bridges (Aspn23/Lysn28) and inter-
chain salt-bridges (Aspn23/Lysn-128), where n stands for the chain
number. Moreover, the majority of the salt-bridges were
maintained during the whole simulation time, reaching an
average distance between the center of mass of the carboxyl
group of Asp23 and the center of mass of the NH3+ group of
Lys28 of 0.32 nm (0.03) for simulation E5, and of 0.38 nm (0.19)
for simulation E3. Also, as illustrated in Figure 6, it can be
concluded that, for those salt-bridges where Asp223 took part
in, an average distance of 0.58 nm (0.15) was reached after
approximately 32 ns, which was kept until the end of the
simulation. On the other hand, salt-bridges involving Asp523 were
broken (∼43 ns, Asp523/Lys528, Figure 7C) or displayed large
fluctuations (∼50 ns, Asp523/Lys428, Figure 7D), since after a
certain amount of simulation time this negatively charged amino
Figure 4. CR root mean square deviation (rmsd) and root mean square fluctuation (rmsf) as a function of time and plotted against the number of
residues for (A and B) trimeric aggregate and (C and D) pentameric aggregate.






































































acid residue was totally solvated by molecules of water. Figure
S5 in the Supporting Information shows the distance between
the center of mass of the carboxyl group of Asp23 and the center
of mass of the NH3+ group of Lys28 for the trimeric system. In
this case, the intrachain salt-bridges and the interchain salt-
bridges were formed and broken over the entire simulation time.
In the case of trimeric aggregates, large fluctuations occurred,
salt-bridges being formed and broken over the entire simulation
time, which may explain, at least in part, the higher flexibility
of the trimeric system compared to the pentameric conformation
(Figure S5, Supporting Information). Also, as reported before
for A1-40 fibrils,40,55 we find narrow water channels solvating
the Asp23/ Lys28 salt-bridges within the aggregates. Indirect
experimental evidence for interior hydration of A-fibrils comes
Figure 5. Change in the secondary structure during molecular dynamics simulation for both trimeric (A) and pentameric (B) model systems.






































































from differential scanning calorimetry,62 although ssNMR data
do not indicate large structural differences between lyophilized
and wet fibrils.39,58 Visual inspection reveals the formation of
narrow water channels solvating the interior Asp23/Lys28 salt-
bridges into the aggregates. Recent simulations of fibrils with
up to 32 A16-22 peptides in antiparallel -strands have also
shown similar water channels hydrating the Lys16/Glu22 side
chains.56 In several instances, we noted an exchange in the salt-
bridge partners from the initial Asp23/Lys28 pair to Glu22/Lys28
as the end peptides begin to dissociate from the aggregates
(Figure S6, Supporting Information). Figure S6 in the Supporting
Information displays the distance between the center of mass
of the carboxyl group of Glu22 and the center of mass of the
NH3+ group of Lys28 for the intrachain salt-bridges (Glun22/
Lysn28) and the interchain salt-bridges (Glun22/Lysn-128) for the
pentameric case. The presence of Glu22/Lys28 salt-bridges has
been suggested for small A-peptide aggregates, A-monomers
in solution,38,45,77,78 and A1-40 fibrils.55 The Glu22/Lys28 ion pair
might play an important role in the aggregate elongation.55
Overall, on the basis of our own and other previous studies,
the main driving force for fibril elongation appears to be the
formation of C-terminal -sheets (our 2 portion). This hy-
pothesis seems to be supported by recent experiments showing
that perturbing the hydrogen bonds in the 1 and 2 portions
through selective N-methylation affects both fibril growth and
structure.43 Disrupting the backbone hydrogen bonds of the 1
portion resulted in relatively slow growth of fibrils with a blurred
boundary, while derangement of the 2 hydrogen bonds had
less effects on fibril growth and yielded fibrils with a sharply
defined surface. These experimental results are consistent with
our simulation findings.
Figure 8 displays the formation of a -helix structure
occurring especially on the 2 portion of the pentamers. In order
to quantify the twist of this -helix motif, two dihedral angles
were defined, namely, γ and δ. Using as a pivot the amino acid
residue Val36, which encompasses the 2 portion of our model,
the definition of the γ angle involves the CR’s of residues Ilen31,
Valn36, Valn-136, and Ilen-131, while the definition of the δ angle
involves residues Alan42, Valn36, Valn-136, and Alan-142. Parts A
and B of Figure 8 show a spatial view of the 2 portion at 0
and 100 ns of simulation time, respectively. Top views (Figure
8A1 and B1) and lateral views (Figure 8A2 and B2) are also
shown. Parts C and D of Figure 8 illustrate the temporal
development of the γ and δ angles, respectively.
The -helix is a plausible structural motif for amyloid fibrils,
since it is primarily a -sheet structure with the proper cross-
orientation79-82 and known to occur in bona fide proteins. As
described above, in our model of A1-42 aggregates in solution,
the formation of a -helix structure occurred especially on the
2 portion (Figure 8). The model used by us is an elaboration
of the classical cross- molecular structure, which permits the
incorporation of the favorable twisted -sheet structures. This
kind of helical structure enables the hydrogen bonding between
the -strands to be extended over the total length of the amyloid
fibrils, thereby accounting for their characteristic rigidity and
stability.15 Increased fibril twisting could be caused by the loss
of directional hydrogen bonding, and a gain in packing
interactions.83 A schematic definition of those angles is shown
in Figure 8A. In general, after approximately 20 ns of simulation,
an average value of -8.95° (0.97) and -9.40° (1.93) was
reached for γ and δ, respectively. In Figure 8C, a great
fluctuation for the δ angle can be observed. This may be caused
by the fact that the definition of this angle involves the CR of
the terminal residues Ala42, which are in direct contact with
the solvent and therefore leading to a greater mobility. Since
twisted -sheets optimize the hydrogen bonds, side-chain
stacking, and electrostatic interactions, it is commonly accepted
that twisted sheets are more stable than flat ones. This result is
in good agreement with those reported by Periole et al. that
shows the formation of a cross- by the peptide GNNQQNY
with a twist ranging from 0 to 12° per peptide around its axis
when fully solvated.84
Although our model is a full-length model for A1-42
aggregates in solution, it is of interest to compare our results to
other proposed truncated and/or full-length models for A1-40
TABLE 2: Summarized Average Percentage of the
Secondary Structural Composition of the Different Regions
and Portions of the A-Aggregates in Solution (The Average





structure DR 1 turn 2
trimeric extendedb 15.1 (3.1) 24.4 (7.0) 0.0 63.1 (7.7)
helicalc 4.5 (2.9) 0.0 0.0 0.0
bendd 28.3 (4.7) 7.4 (4.0) 0.8 (3.3) 0.5 (1.0)
coile 52.4 (4.5) 68.2 (6.4) 99.2 (3.4) 36.4 (7.8)
pentameric extendedb 5.2 (1.3) 29.3 (5.3) 6.5 (5.8) 63.7 (4.4)
helicalc 4.4 (3.1) 0.00 0.00 0.00
bendd 36.1 (3.6) 0.6 (1.1) 0.7 (2.3) 0.00
coile 54.2 (2.1) 70.1 (5.5) 92.7 (6.1) 36.3 (4.4)
a The standard deviation is given in parentheses. b Extended )
-strand + -bridge. c Helical ) R-helix + 310-helix (3-helix) +
π-helix (5-helix). d Bend ) turns type I-IV + bend. e Coil )
unstructured.
Figure 6. Average interchain distances of the mass center of the CR’s
versus time of the different regions and portions of the trimeric (A)
and pentameric (B) system.






































































structures. The so-called Tycko model39 and the LECB model85
are similar to our model, specifically, regarding the hairpin shape
of the aggregates. There is a slight difference between our model
and the Tycko model. Our model forms a hydrophobic core
with Leu34 facing the interior of the aggregate in the 2 portion,
whereas in Tycko’s model the Leu34 faces outside. In our model,
it was observed that the residues Leu34 and Val36 of the portion
2 formed an inner hydrophobic core in the aggregates.
Regarding this matter, our model is more similar to the LECB
model than Tycko’s. The internal Asp23/Lys28 salt-bridge
interaction is supported by experimental and theoretical
data.16,39,54,57,85 This interaction has been observed in our model,
as well as in the above-mentioned models. We note that the
position of the turn in our model differs from the position of
the same moiety in the LECB model. The turn portion
encompasses the residues Asn27-Ala30 in our model, while the
same portion encompasses the residues Val24-Asn27 in the
LECB model. As a result of this organization, the Asp23/Lys28
salt-bridge shows a slight difference between the LECB model
and our model. In the LECB model, the Asp23 residue is located
in one of the -strands of the peptide, and the Lys28 residue is
located in the other -strand segment; therefore, the Asp23/Lys28
interaction occurs in between the two -strand portions of this
model. In our model, the Asp23 is located in the 1 portion,
while the Lys28 is located in the turn portion. A closely related
structural model for A1-40 fibrils has been proposed by Wetzel
et al.86,87 In agreement with our model, Wetzel’s model places
the side chains of Phe19, Ile32, Leu34, and Val36 in the interior
of a single molecular layer. In contrast to our model, side chains
of Asp23 and Lys28 are on the exterior of a single molecular
layer. A highly similar molecular organization has been
described for another peptide with amyloidogenic properties.
The molecular structural organization of the CA150.WW2
protofilament79 is stabilized by interdigitated hydrophobic
regions, as well as by the presence of a intrachain salt-bridge
between the Glu7 and Arg24 in a parallel -sheet arrangement.
This structural model has similarities to those reported for
aggregates of the A1-4057 and A1-42 peptides16 and the
structure reported for the peptide Sup35.82 Beyond the stabiliza-
tion effect due to the long-range interactions (e.g., salt-bridge
formation) depending on sequence composition, length, and
environmental conditions, the interdigitating hydrophobic side-
chain interactions of the aggregates seem to be a commonly
recurring feature of these aggregates.
In summary, the contributions of the different structural
elements of the full-length A1-42 aggregates in solution to their
stability and conformational dynamics were explored. Using
multiple 20-100 ns long MD simulations of fibril systems of
∼60 000 atoms, we studied aggregate models that differ in the
quantity of peptide chains, notably pentameric and trimeric
aggregates. We found that our models are stable at a temperature
of 310 K, and converge toward an interdigitated side-chain
packing for intermolecular contacts within the two parallel
-sheet regions of the aggregates, 1 (residues 18-26) and 2
(residues 31-42). In spite of the fact that those chains at the
edge of the aggregates showed a higher mobility than those
chains near the aggregate core, the -sheet region kept its
arrangement (1-turn-2/hairpin shape) during the entire simu-
Figure 7. Simplified image of the starting configuration (A) and the final configuration (B) after 100 ns of the interaction Asp23/Lys28 for the
pentameric system. The distance between the center of mass of the carboxyl group of Asp23 and the center of mass of the NH3+ group of Lys28
versus time for the interactions Aspn23/Lysn28 (C; intrachain salt-bridge) and Aspn23/Lysn-128 (D; interchain salt-bridge), where n stands for the
peptide chain number, is also shown.






































































lation time. The 1 portion showed to be more flexible than
the 2 portion, which may well be induced by the proximity of
the disordered region to the 1 portion. This provides good
arguments to study the full-length A-models, since the dynamic
behavior of a determinate portion of the aggregate can affect
the behavior of its surroundings. The Asp23/Lys28 salt-bridges
maintain a stable and relatively rigid interdigitated structure.
However, during the initial stages of fibril dissociation, the
Asp23/Lys28 contacts in A-peptides at the aggregate ends can
break to form the competing Glu22/Lys28 interaction. Thus, it
suggests that the loss of Glu22/Lys28 contacts could be an
important indicator for the transition of the A-peptides from
their solution structures toward the aggregated conformations.45,55
Our whole molecule simulations reveal that the -strand twist
is a characteristic element of A-aggregates, permitting a
compact, interdigitated packing of side chains from neighboring
-sheets. The 2 portion formed a very well organized -helix,
whereas the 1 portion did not reach such a high level of
organization, although it maintained its -sheet conformation.
Conclusions
This study demonstrates the importance of studying the full-
length A-aggregates in solution in order to have a more general
view of how each part of the aggregate influences the confor-
mational behavior of the whole system. Moreover, these
simulations suggest that the hydrophobic core comprising the
2 portion of the aggregate is a crucial stabilizing element in
the process of aggregation and possibly in the elongation of
A-aggregates. For that reason, the 2 portion appears to be a
promising target for further drug design based on the structure-
stability information, such as new potential “amyloid inhibitors”
capable of interacting specifically with this portion of the
aggregates.
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Figure 8. Simplified images of the starting configuration (A1, top view; A2, lateral view) and the final configuration (B1, top view; B2, lateral
view) after 100 ns of the 2 portion for the pentameric system. The γ (C) and δ (D) dihedral angles versus time are also shown. The definition of
the γ dihedral angle involves the CR’s of residues Ilen31, Valn36, Valn-136, and Ilen-131, while the definition of the δ dihedral angle involves residues
Alan42, Valn36, Valn-136, and Alan-142, where n stands for the number of the peptide chain.
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